Lannett Company
LCI
$0.69
Share price
0.00%
Change (1 day)
-69.93%
Change (1 year)
Categories
Operating Margin for Lannett Company (LCI)
Operating Margin as of May 2024 (TTM): -43.36%
According to Lannett Company's latest financial reports and stock price the company's current Operating Margin is -43.36%. At the end of 2022 the company had an Operating Margin of -68.68%.
Operating Margin history for Lannett Company from 2001 to 2022
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2022 | -68.68% | 8.58% |
| 2021 | -63.25% | 609.9% |
| 2020 | -8.91% | -83.13% |
| 2019 | -52.83% | -807.82% |
| 2018 | 7.46% | 8548.83% |
| 2017 | 0.09% | -99.21% |
| 2016 | 10.98% | -80.35% |
| 2015 | 55.90% | 70% |
| 2014 | 32.88% | 140.12% |
| 2013 | 13.69% | 154.49% |
| 2012 | 5.38% | -919.64% |
| 2011 | -0.66% | -106.41% |
| 2010 | 10.24% | 14.25% |
| 2009 | 8.96% | -215.01% |
| 2008 | -7.79% | 8.71% |
| 2007 | -7.17% | -153.85% |
| 2006 | 13.32% | -111.11% |
| 2005 | -119.87% | -467.41% |
| 2004 | 32.63% | -27.05% |
| 2003 | 44.72% | 0.51% |
| 2002 | 44.50% | 89.61% |
| 2001 | 23.47% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 22.88% | -152.77% | 🇺🇸 USA |
 Novartis NVS | 17.27% | -139.83% | 🇨🇭 Switzerland |
 Pfizer PFE | 34.61% | -179.82% | 🇺🇸 USA |
 Abbott Laboratories ABT | 15.60% | -135.98% | 🇺🇸 USA |
 GlaxoSmithKline GSK | 22.54% | -151.98% | 🇬🇧 UK |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.